GMVDF
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2022 Q2 | -25.31 | $2M | -$18M |
| 2021 Q4 | -25.94 | $2M | -$11M |
| 2021 Q2 | -17.85 | $3M | -$1M |
| 2020 Q4 | -29.35 | $3M | -$3M |
| 2020 Q2 | -1.57 | $2M | -$3M |
| 2019 Q4 | -3.48 | $3M | -$689,000 |
| 2019 Q2 | -3.02 | $3M | — |
| 2018 Q4 | -4.08 | $2M | — |